Wednesday, February 14, 2018 -- Consumption of a ketone supplement lowers blood sugar levels and may therefore help diabetics to control spikes in blood sugar, suggests a new study.
Thursday, February 15, 2018 -- (Natural News) Recent findings of Korean scientists suggest that increasing folate intake could help protect women against type-2 diabetes, as concluded in a Diabetes.co.uk article. Also known as Vitamin B9 folic acid (when taken as a synthetic supplement), folate is an essential vitamin involved in the creation of healthy proteins, DNA, and cell division. As it cannot... Read More
Tuesday, February 13, 2018 -- Researchers have found that adopting a vegan diet has the potential to prevent type 2 diabetes in people who are overweight or obese.
Wednesday, February 14, 2018 -- There is all sorts of clinical data to back up the benefits of continuous glucose monitors (CGM) and people with diabetes on social media often praise the CGM for making life better, but researchers have recently sought to improve the data available on real-world use. They conducted a prospective, observational, multi-center cohort study to look […]
Wednesday, February 14, 2018 -- A clinical trial is currently recruiting eligible patients with type 2 diabetes to determine whether intermittent insulin therapy can preserve the functioning of the beta cells in the pancreas. Individuals with type 2 diabetes either do not make enough insulin or their bodies do not properly respond to the insulin produced. Insulin, a hormone that […] The post In the Pipeline: Early Intermittent Insulin Therapy for Type 2 Diabetes appeared first on Medical News Bulletin | Health News and Medical Research.
Tuesday, February 13, 2018 -- A new study takes a deep look at the connection between shift work and type 2 diabetes. Investigators at Brigham and Women's Hospital leveraged data on hundreds of thousands of people in the UK Biobank to better understand how shift work - especially frequent night work - contributes to the likelihood of type 2 diabetes.
Thursday, February 15, 2018 -- A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.
Monday, February 12, 2018 -- Roivant Sciences, led by biotech entrepreneur Vivek Ramaswamy, has signed a development and licensing agreement with Poxel for the development of a potential oral type 2 oral diabetes drug, imeglimin. Last year Roivant raised $1.1 billion from an ...
Monday, February 12, 2018 -- Results of the PRECISE II study showed the implanted continuous glucose monitoring (CGM) system from Eversense to be safe and highly accurate over the 90-day sensor life in patients with type 1 or type 2 diabetes.
Thursday, February 15, 2018 -- Researchers who analyzed data from the UK's National Pregnancy in Diabetes Audit found concerning shortcomings in pregnancy preparation and prenatal care for women with diabetes. In addition, significant clinic-to-clinic variation across the England and Wales suggests opportunities for improvement.
Monday, February 12, 2018 -- European regulators have issued a green light for Novo Nordisk’s once-weekly diabetes therapy Ozempic.
Thursday, February 15, 2018 -- A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville. The study was published online this […]
Monday, February 12, 2018 -- Novo Nordisk’s Ozempic (semaglutide) has secured marketing authorization from the European Commission (EC) for the treatment of adults with type 2 diabetes.
Wednesday, February 14, 2018 -- Background: Intensive lifestyle change can treat and even reverse type 2 diabetes. Digital therapeutics have the potential to deliver lifestyle as medicine for diabetes at scale. Objective: This 12-week study investigates the effects of a novel digital therapeutic, FareWell, on hemoglobin A1c (HbA1c) and diabetes medication use. Methods: Adults with type 2 diabetes and a mobile phone were recruited throughout the United States using Facebook advertisements. The intervention aim was to effect a sustainable shift to a plant-based dietary pattern and regular exercise by advancing culinary literacy and lifestyle skill acquisition. The intervention was delivered by an app paired with specialized human support, also delivered digitally. Health coaching was provided every 2 weeks by telephone, and a clinical team
Monday, February 12, 2018 -- MedicalResearch.com Interview with: Rachel McGrath BSc (Hons), PhD Senior Research Fellow – Department of Endocrinology, RNSH Clinical Senior Lecturer – Northern Clinical School University of Sydney MedicalResearch.com: What is the background for this study? What are the main findings? Response: Women with type … Continue reading →
Thursday, February 15, 2018 -- Gut bacteria and insulin resistance affect our digestion, and according to a new study by John Hopkins researchers, they are also linked to obesity. Why is gut bacteria important? It is a well-known fact that our intestines have bacteria also … The post Gut bacteria and insulin resistance linked with obesity: Study appeared first on Bel Marra Health - Breaking Health News and Health Information.
Monday, February 12, 2018 -- Women with gestational diabetes have a greater risk of developing T2D and cardiovascular events than women who were not previously diagnosed with the disease.
Tuesday, February 13, 2018 -- The ADA's updates include a modified patient-focused care algorithm as well as improved risk management for CVD.
Tuesday, February 13, 2018 -- A recent study assessed the relationship of fasting neuropeptide Y with insulin resistance, β-cell function, and glucagon-like peptide-1 secretion in patients with migraine.
Thursday, February 15, 2018 -- Microvascular decompression for trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia was found to be a largely safe procedure.